首页> 美国卫生研究院文献>Marine Drugs >Antidiabetic Activity of Differently Regioselective Chitosan Sulfates in Alloxan-Induced Diabetic Rats
【2h】

Antidiabetic Activity of Differently Regioselective Chitosan Sulfates in Alloxan-Induced Diabetic Rats

机译:不同区域选择性壳聚糖硫酸盐对四氧嘧啶所致糖尿病大鼠的抗糖尿病活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study investigated and compared the hypoglycemic activity of differently regioselective chitosan sulfates in alloxan-induced diabetic rats. Compared with the normal control rats, significantly higher blood glucose levels were observed in the alloxan-induced diabetic rats. The differently regioselective chitosan sulfates exhibited hypoglycemic activities at different doses and intervals, especially 3-O-sulfochitosan (3-S). The major results are as follows. First, 3,6-di-O-sulfochitosan and 3-O-sulfochitosan exhibited more significant hypoglycemic activities than 2-N-3, 6-di-O-sulfochitosan and 6-O-sulfochitosan. Moreover, 3-S-treated rats showed a more significant reduction of blood glucose levels than those treated by 3,6-di-O-sulfochitosan. These results indicated that –OSO3 at the C3-position of chitosan is a key active site. Second, 3-S significantly reduced the blood glucose levels and regulated the glucose tolerance effect in the experimental rats. Third, treatment with 3-S significantly increased the plasma insulin levels in the experimental diabetic rats. A noticeable hypoglycemic activity of 3-S in the alloxan-induced diabetic rats was shown. Clinical trials are required in the future to confirm the utility of 3-S.
机译:本研究调查和比较了不同区域选择性壳聚糖硫酸盐在四氧嘧啶诱导的糖尿病大鼠中的降血糖活性。与正常对照组相比,在四氧嘧啶诱导的糖尿病大鼠中观察到明显更高的血糖水平。不同的区域选择性壳聚糖硫酸盐在不同的剂量和间隔下表现出降血糖活性,尤其是3-O-磺基壳聚糖(3-S)。主要结果如下。首先,3,6-二-O-磺基壳聚糖和3-O-磺基壳聚糖比2-N-3、6-di-O-磺基壳聚糖和6-O-磺基壳聚糖表现出更显着的降血糖活性。此外,与3,6-di-O-磺基壳聚糖治疗的大鼠相比,经3S治疗的大鼠显示出更显着的血糖水平降低。这些结果表明,壳聚糖C3位上的–OSO3 -是关键的活性位点。其次,3-S明显降低了实验大鼠的血糖水平,并调节了葡萄糖耐量的作用。第三,在实验性糖尿病大鼠中,用3-S治疗显着增加血浆胰岛素水平。显示了在四氧嘧啶诱导的糖尿病大鼠中3-S的明显降血糖活性。将来需要进行临床试验以确认3-S的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号